Quest Non Current Liabilities Total vs Cash And Short Term Investments Analysis
DGX Stock | USD 141.97 2.64 1.89% |
Quest Diagnostics financial indicator trend analysis is much more than just breaking down Quest Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quest Diagnostics is a good investment. Please check the relationship between Quest Diagnostics Non Current Liabilities Total and its Cash And Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Non Current Liabilities Total vs Cash And Short Term Investments
Non Current Liabilities Total vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quest Diagnostics Non Current Liabilities Total account and Cash And Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Quest Diagnostics' Non Current Liabilities Total and Cash And Short Term Investments is 0.55. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Quest Diagnostics Incorporated, assuming nothing else is changed. The correlation between historical values of Quest Diagnostics' Non Current Liabilities Total and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Quest Diagnostics Incorporated are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Non Current Liabilities Total i.e., Quest Diagnostics' Non Current Liabilities Total and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.55 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Non Current Liabilities Total
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Quest Diagnostics balance sheet. This account contains Quest Diagnostics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Quest Diagnostics Incorporated fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Quest Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quest Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. At this time, Quest Diagnostics' Discontinued Operations is fairly stable compared to the past year. Tax Provision is likely to rise to about 266.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.2B | 3.4B | 3.1B | 2.7B | Total Revenue | 10.8B | 9.9B | 9.3B | 6.9B |
Quest Diagnostics fundamental ratios Correlations
Click cells to compare fundamentals
Quest Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Quest Diagnostics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Short Long Term Debt Total | 5.3B | 4.7B | 4.7B | 4.6B | 5.4B | 3.1B | |
Other Current Liab | 778M | 1.2B | 1.2B | 1.1B | 1.5B | 1.6B | |
Total Current Liabilities | 2.0B | 1.8B | 1.8B | 1.6B | 1.8B | 1.2B | |
Total Stockholder Equity | 5.6B | 6.8B | 6.4B | 5.9B | 6.3B | 3.9B | |
Property Plant And Equipment Net | 2.0B | 2.2B | 2.3B | 2.4B | 2.4B | 2.5B | |
Net Debt | 4.1B | 3.5B | 3.8B | 4.3B | 4.7B | 2.7B | |
Retained Earnings | 8.2B | 9.3B | 7.6B | 8.3B | 8.8B | 9.3B | |
Accounts Payable | 263M | 446M | 357M | 324M | 1.4B | 1.4B | |
Cash | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Non Current Assets Total | 10.4B | 11.0B | 10.9B | 10.9B | 11.7B | 6.9B | |
Non Currrent Assets Other | 160M | 176M | 163M | 144M | 198M | 176.0M | |
Cash And Short Term Investments | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
Net Receivables | 1.1B | 1.5B | 1.4B | 1.2B | 1.2B | 892.3M | |
Liabilities And Stockholders Equity | 12.8B | 14.0B | 13.6B | 12.8B | 14.0B | 8.5B | |
Non Current Liabilities Total | 5.1B | 5.4B | 5.3B | 5.3B | 5.8B | 3.3B | |
Inventory | 123M | 223M | 208M | 192M | 190M | 104.0M | |
Other Current Assets | 112M | 157M | 223M | 196M | 286M | 227.8M | |
Other Stockholder Equity | (2.5B) | (2.5B) | (1.2B) | (2.4B) | (2.5B) | (2.4B) | |
Total Liab | 7.1B | 7.1B | 7.0B | 6.8B | 7.6B | 4.6B | |
Property Plant And Equipment Gross | 2.0B | 2.2B | 2.3B | 2.4B | 5.8B | 6.1B | |
Total Current Assets | 2.5B | 3.1B | 2.7B | 1.9B | 2.4B | 1.6B | |
Accumulated Other Comprehensive Income | (59M) | (39M) | (21M) | (14M) | 14M | 14.7M | |
Short Term Debt | 949M | 143M | 153M | 155M | 456M | 241.5M | |
Intangible Assets | 1.2B | 1.1B | 1.2B | 1.1B | 1.2B | 968.0M | |
Other Liab | 683M | 847M | 792M | 812M | 933.8M | 472.6M | |
Other Assets | 64M | 1.3B | 163M | 144M | 165.6M | 196.9M | |
Long Term Debt | 4.0B | 4.0B | 4.0B | 4.0B | 4.4B | 3.0B | |
Property Plant Equipment | 1.5B | 1.6B | 2.3B | 2.4B | 2.7B | 2.8B | |
Good Will | 6.6B | 6.9B | 7.1B | 7.2B | 7.7B | 5.7B | |
Treasury Stock | (5.2B) | (5.4B) | (3.5B) | (4.7B) | (4.2B) | (4.4B) | |
Net Tangible Assets | (1.6B) | (700M) | (1.8B) | (1.9B) | (2.1B) | (2.2B) | |
Noncontrolling Interest In Consolidated Entity | 46M | 50M | 39M | 37M | 42.6M | 34.3M | |
Retained Earnings Total Equity | 8.2B | 9.3B | 7.6B | 8.3B | 9.5B | 6.6B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Quest Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Quest Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Quest Diagnostics Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Quest Diagnostics Incorporated Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 2.88 | Earnings Share 7.43 | Revenue Per Share 83.105 | Quarterly Revenue Growth 0.015 |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.